Status:
RECRUITING
Optimization of the Targeted Anticancer Therapies
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Collaborating Sponsors:
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Krebsforschung Schweiz, Bern, Switzerland
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anti...
Detailed Description
Targeted anticancer therapies are often prescribed at the same dosage regimen in all patients. However, it is known that the marked interindividual variability in drug level may affect treatment outco...
Eligibility Criteria
Inclusion
- Cancer patients to whom a targeted anticancer therapy is prescribed
Exclusion
- Patients incapable of judgment or participants under tutelage
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04484064
Start Date
May 1 2015
End Date
December 1 2030
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUV
Lausanne, Canton of Vaud, Switzerland, 1011